Online Patient Portal Use May Up Likelihood of Kidney Transplant – Renal and Urology News
Portal users more likely to have received kidney transplant at 4, 5 years after initiating dialysis.
Related Articles
MRI Predicts Prostate Cancer Upgrading at First Active Surveillance Biopsy
MRI around the time of diagnostic biopsy may identify patients at increased risk for early reclassification during prostate cancer active surveillance.
Apalutamide vs Enzalutamide for mCSPC Offers Better Survival, Real-World Data Show
Investigators examined overall survival among real-world patients with metastatic prostate cancer (mCSPC) initiating enzalutamide vs apalutamide.
Genetic Kidney Stone Disease Is Uncommon
Genetic kidney stone disease affects only a minority of stone formers, according to research.
Sacubitril-Valsartan Combo More Effective for Thrombotic Microangiopathy
Treatment strategies have not been well established for thrombotic microangiopathy associated with malignant hypertension.
Weight-Adjusted Waist Index Positively Tied to Overactive Bladder
Association stronger than with other obesity-related indicators
Timing of Metastatic Prostate Cancer Onset, Metastatic Burden Affect Outcomes
Among patients with metastatic hormone-sensitive prostate cancer (mHSPC), patients with de novo vs secondary mHSPC are more likely to progress to castration-resistant disease.
AHA and ACC Update Cardiovascular Management Guideline for Noncardiac Surgery
Stepwise approach to perioperative cardiac management can help doctors decide whether surgery should proceed
Apalutamide vs Enzalutamide for mCSPC Offers Better Survival, Real-World Data Show
Investigators examined overall survival among real-world patients with metastatic prostate cancer (mCSPC) initiating enzalutamide vs apalutamide.
Short-Term ADT Improves Upon High-Dose Radiotherapy in Localized Prostate Cancer
Combining short-term ADT with high-dose radiotherapy can improve some outcomes in patients with localized prostate cancer.
Sacubitril-Valsartan Combo More Effective for Thrombotic Microangiopathy
Treatment strategies have not been well established for thrombotic microangiopathy associated with malignant hypertension.